Serpentis Inquest

From EVE University Wiki
Revision as of 21:11, 30 August 2019 by Felyza (talk | contribs) (Still exists in game, no valid reason on deletion note. Removed deletion macro.)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Icon large green check.png
The UniWiki's software has been successfully upgraded on the 2024-06-22. If you notice any issues, please tell us about them using Wiki Communication Channels.
Wiki Manager, Arin Mara

The Serpentis Inquest is a offspring of the Serpentis Corporation that is also a research company, but instead of focusing on neural boosters Inquest is researching black cyber implants and alternative cloning methods.

Attributes

  • Ticker: SPI
  • Headquarters: Serpentis Prime VI - Moon 1 - Serpentis Inquest Biotech Research Center
  • Offices: 1 in 1 systems
  • Shares: 332427989
  • Share price: 81
  • Activity: Biotech
  • Partner: Eifyr and Co.
  • Competitor: Zero-G Research Firm

CEO

Otuwiri Huohalen

Divisions

Administration

  • CFO: Achi Astenaisen

Intelligence

  • Chief Operative: Onlar Skadidsar

Production

  • Production Manager: Engardin Trahad

Personnel

  • Chief of Staff: Ersi Argrik
Retrieved from "https://wiki.eveuniversity.org/index.php?title=Serpentis_Inquest&oldid=145112"